SC 13G/A 1 m020123a.htm SCHEDULE 13G/A (AMENDMENT NO. 1)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

Medicus Sciences Acquisition Corp.

(Name of Issuer)

Class A ordinary shares, $0.0001 par value

(Title of Class of Securities)

G5960S108

(CUSIP Number)

December 31, 2022

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. G5960S108

13G

Page 2 of 7 Pages

1	NAME OF REPORTING PERSON Third Point LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ☐ (b) ☐
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER 0
		6	SHARED VOTING POWER 0
		7	SOLE DISPOSITIVE POWER 0
		8	SHARED DISPOSITIVE POWER 0
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* N/A
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0.0%
12	TYPE OF REPORTING PERSON OO

CUSIP No. G5960S108

13G

Page 3 of 7 Pages

1	NAME OF REPORTING PERSON Daniel S. Loeb
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ☐ (b) ☐
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER 0
		6	SHARED VOTING POWER 0
		7	SOLE DISPOSITIVE POWER 0
		8	SHARED DISPOSITIVE POWER 0
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* N/A
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0.0%
12	TYPE OF REPORTING PERSON IN

This Amendment No. 1 to Schedule 13G (this “Amendment No. 1”) is being filed with respect to the Class A ordinary shares, $0.0001 par value ("Class A Ordinary Shares") of Medicus Sciences Acquisition Corp. (the "Issuer"), to amend the Schedule 13G filed by the Reporting Persons on February 14, 2022 (the “Schedule 13G”). This Amendment No. 1 is being filed to report changes in the number of shares of Class A Ordinary Shares beneficially owned by the Reporting Persons and to report that the Reporting Persons no longer beneficially own more than 5 percent of the Class A Ordinary Shares. Capitalized terms used herein and not otherwise defined have the meanings ascribed to them in the Schedule 13G.

Item 1(a): Name of Issuer:

Medicus Sciences Acquisition Corp.

Item 1(b): Address of Issuer's Principal Executive Offices:

The Issuer's principal executive offices are located at 152 West 57th Street, Floor 20, New York, New York 10019.

Item 2(d): Title of Class of Securities:

Class A ordinary shares, $0.0001 par value.

Item 2(e): CUSIP Number:

G5960S108.

Item 4: Ownership:

A. Third Point LLC

(a) Amount beneficially owned: -0-

(b) Percent of class: 0.0%. The percentages used herein and in the rest of this Schedule 13G are calculated based upon the 9,292,000 Class A Ordinary Shares issued and outstanding as of November 14, 2022, as reported in the Issuer’s quarterly report on Form 10-Q for the quarterly period ended September 30, 2022, as filed with the U.S. Securities and Exchange Commission on November 14, 2022.

(i)	Sole power to vote or direct the vote: -0-
(ii)	Shared power to vote or direct the vote: -0-
(iii)	Sole power to dispose or direct the disposition: -0-
(iv)	Shared power to dispose or direct the disposition: -0-

B. Daniel S. Loeb

(a) Amount beneficially owned: -0-

(i)	Sole power to vote or direct the vote: -0-
(ii)	Shared power to vote or direct the vote: -0-
(iii)	Sole power to dispose or direct the disposition: -0-
(iv)	Shared power to dispose or direct the disposition: -0-

Item 5: Ownership of Five Percent or Less of a Class:

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following: ☒

Item 10: Certification:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

[Signatures on following page]

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 10, 2023

	THIRD POINT LLC

	By: Daniel S. Loeb, Chief Executive Officer

	By:	/s/ William Song
		Name: William Song
		Title: Attorney-in-Fact

	DANIEL S. LOEB

	By:	/s/ William Song
		Name: William Song
		Title: Attorney-in-Fact

EXHIBIT INDEX

Exhibit 99.1:	Joint Filing Agreement, dated February 14, 2022, by and between Third Point LLC and Daniel S. Loeb, was previously filed with the SEC on February 14, 2022 as Exhibit 99.1 to the Schedule 13G and is incorporated herein by reference.
Exhibit 99.2:	Power of Attorney granted by Daniel S. Loeb in favor of William Song and Joshua L. Targoff, dated February 17, 2021, was previously filed with the SEC on March 4, 2021 as Exhibit 24 to the Form 4 filed by Third Point LLC and Daniel S. Loeb with respect to Radius Global Infrastructure Inc. and is incorporated herein by reference.

SEC Form SC 13G/A filed by Medicus Sciences Acquisition Corp. (Amendment)